PRODUCING AND USING EVIDENCE
1. ACHIEVEMENTS, PROBLEMS AND PERSPECTIVE OF RUSSIAN SPEAKING COUNTRIES
2. CLINICAL ASPECTS AND PATIENT SAFETY I
3. CLINICAL ASPECTS AND PATIENT SAFETY II
4. MOLECULAR MECHANISMS CONTRIBUTING TO THE EVIDENCE-BASE
ACHIEVEMENTS, PROBLEMS AND PERSPECTIVE OF
RUSSIAN SPEAKING COUNTRIES
Paradoxes of evidence in Russian addiction medicine V.D. Mendelevich (Kazan, Russia) |
Meta-analysis: problems with Russian publications E.V. Verbitskaya (St.-Petersburg, Russia) |
Evidence-based clinical guidelines in the Kyrgyz Republic A.A. Zurdinova (Bishkek, Kyrgyzstan) |
A. Kolbin (St.-Petersburg, Russia) |
Quality of postgraduate medical education I.G. Nizamov, T.I. Sadykova (Kazan, Russia) |
EBM teaching at the Department of epidemiology of the Kazan Medical University G. Khasanova (Kazan, Russia) |
Improving data retrieval quality: evidence-based medicine perspective V. Dobrynin, J. Balykina, M. Kamalov, A. Kolbin, E. Verbitskaya, M. Kasimova (St.-Petersburg, Russia) |
CLINICAL ASPECTS AND PATIENT SAFETY I
Diabetes mellitus: curable or not? EBM perspective S.Yu. Kalinchenko (Moscow, Russia) |
Clinical and electrophysiological aspects of tics in children G.I. Safiullina, A.A. Safiullina (Kazan, Russia) |
Adherence to EBM guidelines in clinical practice R.Kh. Khafizianova, I.M. Burykin (Kazan, Russia) |
CYP3A4 activity and haloperidol effects in alcohol addicts M.S. Zastrozhin (Moscow, Russia) |
Treatment of West syndrome: EBM and our results M.E. Farnosova, R.G. Gamirova (Kazan, Russia) |
Results of pharmacogenetic testing in the Chelyabinsk region V.O Barysheva (Chelyabinsk, Russia) |
Fighting trafficking of falsified and substandard medicinal products in Russia N.F. Fayzrakhmanov (Yoshkar-Ola, Russia) |
Implementation of evidence-based pharmacology in a large multidisciplinary hospital and rational use of medicines A.F. Titarenko, S.V. Evstigneev, T.R. Abakumova, E.G. Alexandrova, V.N. Khaziakhmetova, L.E Ziganshina (Kazan, Russia) |
CLINICAL ASPECTS AND PATIENT SAFETY II
Ch. S. Pavlov (Moscow, Russia) |
Acute kidney injury in neonatal intensive care: medicines involved A.I. Safina, M.A. Daminova (Kazan, Russia) |
Regional specifics of microbial landscape in outpatients with lower respiratory tract infections V.A. Baturin, E.V. Shchetinin, F.T. Malykhin (Stavropol, Russia) |
Mild anemia as a protective factor against pregnancy loss L.O. Buzyan, G.G. Ketova (Chelyabinsk, Russia) |
Effects of balance training on post-sprained ankle joint instability I. Faizullin, E. Faizullina (Erlangen, Germany; Kazan, Russia) |
Implementing EBM principles in tertiary hospital practice A.A. Korableva, R.F. Gaifullin, L.E. Ziganshina (Kazan, Russia) |
Antibiotics for skin and soft tissues infections in type 2 diabetes mellitus T.N. Razdrogina (Volgograd, Russia) |
Experience of a practicing clinical pharmacologist A.Z. Nigmetzyanova (Kazan, Russia) |
CONTRIBUTING TO THE EVIDENCE-BASE
Attention deficit disorder: problem, modeling, pharmacology G.I. Kovalev (Moscow, Russia) |
Pirimidine derivatives as hepatoprotective agents A.B. Vyshtakalyuk, N.G. Nazarov, V.V. Zobov, V. E. Semenov, I.V. Galyametdinova, G.V. Tcherepnev, V.S. Reznic (Kazan, Russia) |
6-Methyluracil derivatives as acetylcholinesterase inhibitors for treatment of Alzheimer's disease I.V. Zueva, V.E. Semenov, M.A. Mukhamedyarov, K.A. Petrov, S.V. Lushchekina, A.D. Kharlamova, E.O. Petukhov, V.V. Zobov, A.S. Mikhailov, S.N. Podyachev, L.F. Saifina, O.A. Minnekhanova, E. E. Nikolsky, P. Masson, V.S. Reznik (Kazan, Russia) |
K. Petrov (Kazan, Russia) |
S. Lushchekina, E. Kots, A. Kharlamov, K. Petrov, P. Masson (Moscow, Kazan, Russia) |
Rat paw oedema modeling and NSAIDs: timing of effects H.H. Cong*, V.N. Khaziakhmetova, L.E. Zigashina (Kazan, Russia) |
The compounds of benzofuroxan series - new NO-donors R. G. Karimova (Kazan, Russia) |
ATP-induced changes in rat skeletal muscle contractility A.I. Gabdrakhmanov, A.E. Khayrullin, C.H. Grishin, A.U. Ziganshin (Kazan, Russia) |